Risk factors for hyperglycemia in COVID-19 patients treated with remdesivir
Description
The primary objective of this study was to investigate the factors contributing to hyperglycemic adverse events associated with the administration of remdesivir in hospitalized patients diagnosed with coronavirus disease 2019 (COVID-19). Furthermore
